E Fund Management (HK)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.1K Buy
524
+150
+40% +$6.45K 0.01% 268
2026
Q1
$13.7K Buy
+374
New +$17.7K 0.01% 286

Other funds holding NVO

E Fund Management (HK)'s NVO Position: Q2 2026 in Review

E Fund Management (HK) increased its Novo Nordisk (NVO) stake by 40% in Q2 2026, buying an estimated $6.45K and bringing the position to 524 shares worth $25.1K. The position accounts for 0.01% of the portfolio, ranked #268.

E Fund Management (HK) first reported a position in NVO in Q1 2026 and has held it in 2 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • E Fund Management (HK) held 524 shares of Novo Nordisk worth $25.1K as of Q2 2026.
  • E Fund Management (HK) bought 150 Novo Nordisk shares in Q2 2026, an estimated $6.45K.
  • Novo Nordisk made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #268 holding.
  • E Fund Management (HK) first reported a position in Novo Nordisk in Q1 2026 and has held it in 2 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.